Motavizumab

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Motavizumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Template:Drugbox-mab

Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is currently being investigated by MedImmune for the prevention of respiratory syncytial virus infection in high-risk infants.

External links

MedImmune

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

Template:Humanizedmonoclonals

Retrieved from "https://www.wikidoc.org/index.php?title=Motavizumab&oldid=608067"

Navigation WikiDoc | WikiPatient | Up To Date Pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Create a New Page | Become an Editor | Editors Help Menu | Upload a Picture or File | Maintain Pages | What Pages Link Here

There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies

Cookies help us deliver our services. By using our services, you agree to our use of cookies.